REFERENCES
- Kenyon C. J., Hooper G., Tierney D., Butler J., Devane J., Wilding I. R. The effect of food on the gastrointestinal transit and systemic absorption of naproxen from a novel sustained release formulation. J. Controlled Release 1995; 34: 31–36
- Wilding I. R., Sparrow R. A., Davis S. S., Horton R. J. The role of gastric emptying in the absorption and metabolism of nifedipine given in a modified release pellet formation. Int. J. Pharm. 1992; 84: 59–67
- Sournac M., Beyssac E., Maublant J., Aiache J., Veyre A., Bougare J. Scintigraphic study of the gastro-intestinal transit of a sustained release theophylline tablet. II. Administration in non-fasting state. J. Controlled Release 1991; 15: 113–120
- Abrahamsson B., Alpsten M., Hugosson M., Jonsson U. E., Sundgren M., Svenheden A., Tolli J. Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release tablet. Pharm. Res. 1993; 10: 709–714
- Davis S. S., Hardy J. G., Fara J. W. Transit of pharmaceutical dosage forms through the small intestine. Gut 1986; 27: 886–892
- Davis S. S., Khosla R., Wilson C. G., Washington N., Leslie S. T. The gastrointestinal transit of controlled release formulation of indomethacin. Int. J. Pharm. 1990; 60: 191–196
- Khosla R., Davis S. S. Gastric emptying and small and large bowel transit of non-disintegrating tablets in fasted subjects. Int. J. Pharm. 1989; 52: 1–10
- Bechgaard H., Nielsen G. H. Controlled-release multiple-units and single-units doses. A literature review. Drug Dev. Ind. Pharm. 1978; 4: 53–67
- Shameen M., Katori N., Aoyagi N., Kojima S. Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans. Pharm. Res. 1995; 12: 1049–1054
- Katori N., Ma W., Aoyagi N., Kojima S. Effect of destructive force on drug release from multiple unit controlled release dosage forms in humans. Pharm. Res. 1996; 13: 1541–1546
- Miyagawa Y., Okabe T., Yamaguchi Y., Miyajima M., Sato H., Sunada H. Controlled-release of diclofenac sodium from wax matrix granule. Int. J. Pharm. 1996; 138: 215–224
- Sato H., Miyagawa Y., Okabe T., Miyajima M., Sunada H. Dissolution mechanism of diclofenac sodium from wax matrix granule. J. Pharm. Sci. 1997; 86: 929–934
- Nakamichi K., Yasuura H., Fukui H., Oka M., Izumi S., Andou T., Shimizu N., Ushimaru K. Preparation of nifedipine-hydroxypropylmethylcellulose phthalate solid dispersion by twin screw extruder and its evaluation. Yakuzaigaku 1996; 56: 15–22
- Sagara K., Nagamatsu Y., Yamada I., Kawata M., Mizuta H., Ogawa K. Bioavailability study of commercial sustained-released preparation of diclofenac sodium in gastrointestinal physiology regulated-dogs. Chem. Pharm. Bull. 1992; 40: 3303–3306
- Evans D. F., Pye G., Bramley R., Clark A. G., Dyson T. J., Hardcastle J. D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988; 29: 1035–1041
- Aoki S., Uesugi K., Tatsuishi K., Ozawa H., Kayano M. Evaluation of the correlation between in vivo and in vitro release of phenyl propanolamine HCl from controlled-release tablets. Int. J. Pharm. 1992; 85: 65–73
- Katori N., Aoyagi N., Terao T. Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation. Pharm. Res. 1995; 12: 237–243
- Ogura T. Design and evaluation of sustained-release dosage form for rhinitis. Proceedings of Dai 14 kai Seizai Seminar. 1989; 132–137, [in Japanese],
- Dressman J. B. Comparison of canine and human gastrointestinal physiology. Pharm. Res. 1986; 3: 123–131
- Yamada K., Furuta A., Akimoto M., Maki T., Suwa T., Ogata H. Evaluation of gastrointestinal transit controlled-beagle dog as a suitable animal model for bioavailability testing of sustained-release acetaminophen dosage form. Int. J. Pharm. 1995; 119: 1–10